Pharmaceuticals

Major Tobacco Manufacturer Selects ArisGlobal's LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes

A multinational tobacco products manufacturing company recently selected ArisGlobal's LifeSphere® MultiVigilance 10 for their global safety vigilance needs MIAMI, Feb. 11, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functio...

2020-02-11 20:30 495

Vakrangee to Revolutionize Rural Healthcare in India: Plans to Rollout Telemedicine Services From vHealth by AETNA (a CVS Health Company)

MUMBAI, India, Feb. 11, 2020 /PRNewswire/ -- Vakrangee Limited (VL) announces alliance with vHealth by Aetna which is fully owned subsidiary of Aetna Inc, a CVS Health Company (Fortune 8 enterprise), one of the world's leading health services providers, to offer a combination of Telemedicine serv...

2020-02-11 16:42 1133

Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries

HONG KONG, Feb. 10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana. Cipla Medp...

2020-02-11 08:51 312

Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules

* Lined up all the sold Newmacor capsules end-to-end would reach 1,043km * Future target growth is to reach blockbuster levels and exceed 10 billion KRW SEOUL, South Korea, Feb. 10, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) is celebrating the 5th anniversary of the ...

2020-02-10 22:00 385

Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020

PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced  the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...

2020-02-10 21:42 3966

Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)

- RRP is a rare, potentially fatal orphan disease caused by Human Papillomavirus (HPV) 6 and 11 - Inovio's DNA medicine pipeline includes 15 clinical programs focused on HPV-associated diseases, cancer, and infectious diseases, including the novel coronavirus (2019-nCoV) PLYMOUTH MEETING, Penns...

2020-02-10 19:00 893

GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours

NANJING, China, Feb. 10, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District, Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CA...

2020-02-10 10:49 426

GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours

NANJING, China, Feb. 6, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District,Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CAMA...

2020-02-06 22:46 407

RhoVac Announces Appointment of Professor Anne J. Ridley to its Scientific Advisory Board

STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6 th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition ofAnne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, ...

2020-02-06 20:22 555

Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer

MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study  by scientists from India, USA, and UK has presented clinical evidence for an innovative test that can detect clusters of cancer cells in the blood of asymptomatic individuals as a...

2020-02-06 08:00 603

Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases

* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...

2020-02-05 13:21 384

Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO

STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...

2020-02-05 06:38 10211

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the fiscal year 2019, reporting 30.9% growth in sales at701.6 billion won, and 64.6% growth in operating profit at91.7 billion won compared to the ...

2020-02-04 13:50 403

Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities

SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a bushfire appeal, aiming to raise$250,000 to support bushfire affected pharmacies in providing free medication and personal care items to their communities. Helen Feng...

2020-02-04 08:15 356

China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus

HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today an...

2020-02-04 06:00 6298

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.  Trefoil is developing products based...

2020-02-04 06:00 493

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...

2020-02-03 21:00 417

Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...

2020-02-03 17:01 477

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...

2020-02-03 17:00 8046

The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year

Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introdu...

2020-01-30 23:09 755
12345 ... 107

Week's Top Stories